Autobahn Therapeutics Aims to Treat MS by Restoring Myelin
Jun 22, 2020, 12:00 AM
Share
Subscribe
Multiple Sclerosis News Today columnist, Jenn Powell discusses Autobahn Therapeutics aim to treat MS by restoring myelin.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/